TFE3 and renal cell carcinoma: In 2004, WHO classified Xp11.2/TFE3 translocation RCC as an independent subtype of renal carcinoma, and in 2016, it was reclassified as microphthalmia‐associated transcription factor (MiTF) RCC subtype.2